Anavex Life Sciences to Present at the Citizens Life Sciences Conference

Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel therapeutics for the treatment of neurodegenerative, neurodevelopmental, ...
The Manila Times

Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Dru…

Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily ...
BioWorld

New muscarinic M4 receptor antagonists reported in Sumitomo Pharma patent

Sumitomo Pharma Co. Ltd. has patented aminomethylcyclohexane derivatives acting as muscarinic M4 receptor antagonists. As such, they are described as potentially useful for the treatment of ...
Clinical Advisor

Healing a Veteran’s Invisible Wounds: Cluster Headache and Suicide Risk

A misdiagnosed emergency nurse’s severe headaches reveal key signs and symptoms of a cluster headache and the importance of ...

Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...